Ashvattha Therapeutics
Latest round
- Series B
Last raised
- Jan 2025
Total raised
- $119M
Investors
- 5
About Ashvattha Therapeutics
Founded in 2015 and based in California, US, Ashvattha Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing novel therapeutics for the treatment of various diseases. In January 2025, Ashvattha Therapeutics, Inc. Ashvattha Therapeutics, Inc. utilizes a proprietary Hydroxyl Dendrimer (HD) platform to produce novel HD therapeutics (hydroxyl dendrimer therapeutics) that selectively target the inflamed tissues or diseased cells in the human body. The company’s precision medicines can be used for the treatment of various therapeutical areas including neurology, ophthalmology, hyperinflammatory, and neuro-oncology.2, OP-801, and D6-B483.
Who invested in Ashvattha Therapeutics
5 investors across 3 rounds
See all investors in Ashvattha Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ashvattha Therapeutics
Who invested in Ashvattha Therapeutics?
Ashvattha Therapeutics has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ashvattha Therapeutics raised?
Ashvattha Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Ashvattha Therapeutics last raise money?
Ashvattha Therapeutics's most recent round on record is a Series B, in Jan 2025.
What does Ashvattha Therapeutics do?
Founded in 2015 and based in California, US, Ashvattha Therapeutics, Inc.
Where is Ashvattha Therapeutics headquartered?
Ashvattha Therapeutics is headquartered in Redwood City, US.
Which VCs invest in companies like Ashvattha Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Ashvattha Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Ashvattha Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.